The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Maintenance treatment with bevacizumab after chemotherapy (CT) plus B in metastatic colorectal cancer: An Italian multicenter retrospective analysis.
L. Moscetti
No relevant relationships to disclose
E. Cortesi
No relevant relationships to disclose
T. Gamucci
No relevant relationships to disclose
I. Sperduti
No relevant relationships to disclose
I. Pavese
No relevant relationships to disclose
D. Franco
No relevant relationships to disclose
D. Alesini
No relevant relationships to disclose
A. Fabbri
No relevant relationships to disclose
R. Grande
No relevant relationships to disclose
D. Gemma
No relevant relationships to disclose
C. Signorelli
No relevant relationships to disclose
E. Ruggeri
No relevant relationships to disclose